Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

SAN DIEGO, Feb. 6, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon , President and CEO, will present at the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City, on Tuesday, February 12th at 3:00PM Eastern Time.

(Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)

ABOUT THE BIO CEO & INVESTOR CONFERENCE
The 15th Annual BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.  This year's conference will feature corporate presentations from more than 150 leading biotechnology and pharmaceutical companies, five Fireside Chats with industry leaders, three Therapeutic Workshops and five Business Roundtables all drawing from seasoned industry executives and analysts. The conference is designed to foster an informative dialogue between institutional investors and senior biotechnology executives about emerging and current investment opportunities. To find out more information on the event, visit http://www.bio.org/events/conferences/bio-ceo-investor-conference

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/lnn7ss/investigation ) has ... on China,s Levothyroxine Market, 2010-2019" report to ... have the greatest effect of promoting growth on ... mainly promote the growth and development of bones, ... (GH) of pipuitary gland can,t work. Besides, pipuitary ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/84p6xc/investigation ... Report on China,s Bromhexine Market, 2010-2019" report to ... incidence of respiratory disease keeps growing and so does ... derivative of vasicine, is a mucolytic agent used in ... viscid or excessive mucus. It can make the phlegm ...
(Date:9/3/2015)... BALTIMORE , September 3, 2015 ... that its subsidiary Lupin Pharmaceuticals, Inc. (Lupin) has ... which is the first and only generic Duloxetine ... strength. Lupin is excited to bring this new ... currently available dosing options for greater flexibility of ...
Breaking Medicine Technology:Investigation Report on China's Levothyroxine Market, 2010-2019 2China Bromhexine Market Report 2015-2019 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the online ... that cannot be passed up. FiltersFast.com, will ship all orders over $50.00 ... filtration product replacements. Take advantage of this promotion now through September 8, 2015. ...
(Date:9/3/2015)... Los Angeles, CA (PRWEB) , ... September 03, 2015 , ... ... his patients as to the best practices when preparing for a bariatric procedure, some ... for a procedure. Apart from the basic instructions typical for many types of surgery ...
(Date:9/3/2015)... New York (PRWEB) , ... September 03, 2015 , ... ... Do”. William Mattar, Esq. believes this does not stop at any certain demographic ... captioning to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The ...
(Date:9/3/2015)... IN (PRWEB) , ... September 03, 2015 , ... ... Rochester, MN, and Indiana University, Indianapolis, have chosen Center for Hospice Care ... from these institutions will train at CHC as part of fulfilling their requirements ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Leadership® and Navigant Center for Healthcare Research and Policy Analysis has found physician ... , While 47 percent of respondents said their organizations conduct some ...
Breaking Medicine News(10 mins):Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3
... , , , , TAMPA, Fla., July ... has formally launched a collaborative focused on the Patient-Centered Medical Home ... reducing healthcare costs. , , With the debut of the ... the healthcare community interested in sharing insights or learning more about ...
... , NEW YORK, July 6 NeoStem, Inc. (Amex: ... collection, processing and long-term storage of adult stem cells ... Alan G. Harris, M.D., Ph.D., FACP, FRCP, as the ... , , Among his responsibilities in this position ...
... Healthcare in Europe is increasingly becoming digitised and there ... systems. However, the wireless technology that is transforming various ... explored by the healthcare industry to support quality maintenance ... handheld devices in the healthcare arena is poised to ...
... July 6 Coapt Systems, Inc. ( www.coaptsystems.com ... FDA-approved hyaluronic acid based dermal filler for the treatment ... "smile lines." Hydrelle is the first FDA-approved hyaluronic ... patient comfort. Proven safe and effective, Hydrelle is ...
... ... the winning video for a contest sponsored by a prominent Washington, DC LASIK ... brighten someone’s day. , ... July 6, 2009 -- In tough times, random acts of kindness and gestures of goodwill ...
... , ... the web,s fastest growing source of information on dentistry,s responsibility in the recognition and management ... the public and doctors. , ... (PRWEB) July 6, 2009 -- Snoring Isn,t Sexy, LLC, the web,s fastest growing source of ...
Cached Medicine News:Health News:Health Integrated Hosts Industry Collaborative Focused on the Patient-Centered Medical Home (PCMH) 2Health News:Health Integrated Hosts Industry Collaborative Focused on the Patient-Centered Medical Home (PCMH) 3Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 2Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 3Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 4Health News:Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan 2Health News:Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan 3Health News:Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan 4Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 2Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 3Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 4Health News:Eye Doctors of Washington Awards DC Resident Free LASIK as Part of its Good Deeds Campaign 2Health News:Eye Doctors of Washington Awards DC Resident Free LASIK as Part of its Good Deeds Campaign 3Health News:Snoring Isn't Sexy, LLC Launches Discussion Forum for the Public 2
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
Renu rewetting drops soothe your eyes and moisturize soft contact lenses to minimize dryness....
Softwear Saline with unique comfort rinsing formula....
Sensitive Eyes sterile saline spray is the preservative-free aerosol saline solution for people with eyes sensitive to preservatives. Used for rinsing soft contact lenses after cleaning or thermal or...
Medicine Products: